Gamma interferon paradoxically inhibits the development of diabetes in the NOD mouse

Journal of Autoimmunity

Volumn 19, Issue 3, 2002, Pages 129-137

  Sobel, Douglas O ^a   Han, Jaeseok ^b   Williams, Joy ^c   Yoon, Ji Won ^b   Jun, Hee Sook ^b   Ahvazi, Behrouz ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Diabetes; Gamma interferon; NOD mouse

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; RECOMBINANT GAMMA INTERFERON; B7 ANTIGEN; CD86 ANTIGEN; CD86 PROTEIN, MOUSE; CELL ADHESION MOLECULE; CYTOKINE; GAMMA INTERFERON; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL DESTRUCTION; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; FEMALE; IMMUNOPHARMACOLOGY; IN VITRO STUDY; INSULITIS; IRRADIATION; MOUSE; NONHUMAN; PANCREAS ISLET; PATHOGENESIS; PRIORITY JOURNAL; SPLEEN CELL; ANIMAL; DRUG EFFECT; GENE; GENETICS; IMMUNOLOGY; METABOLISM; NONOBESE DIABETIC MOUSE; SPLEEN; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; APOPTOSIS; CELL ADHESION MOLECULES; CYTOKINES; DIABETES MELLITUS; FEMALE; GENES, MHC CLASS I; INTERFERON TYPE II; ISLETS OF LANGERHANS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; SPLEEN; T-LYMPHOCYTES;

EID: 0036849492     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.2002.0604     Document Type: Article

References (57)

1. Makino S., Kunimoto D., Muraoka Y., Mizushima Y., Katagiri K., Tochino Y. 1980. Breeding of a non-obese, diabetic strain of mice. Exp. Anim. 29: 1-13
2. Bottazzo G.F., Pujol-Borrell R., Gale E. 1985. Etiology of diabetes: The role of autoimmune mechanisms. In Diabetes Annual. Vol. 1 K.G.M.M. Alberti, L.P. Krall, eds. Elsevier, Amsterdam, p. 52.
3. Fujita T., Yui R., Kusumoto Y., Serizawa Y., Makino S., Tochino Y. 1982. Lymphocyte insulitis in a 'non-obese diabetic (NOD)' strain of mice: An immuno-histochemical and electron microscope investigation. Biochem. Res. 3: 429-443
4. Hayward A.R., Schreiber S. 1989. Neonatal injection of CD3 antibody into non-obese diabetic mice reduced the incidence of insulitis and diabetes. J. Immunol. 143: 1555-1559
5. Koike T., Itoh Y., Ishii T., Ito I., Takabayashi K., Maruyama M., Tomioka H., Yoshida S. 1988. Preventive effect of monoclonal anti-L3T3 antibody on development of diabetes in NOD mice. Diabetes 36: 539-541
6. Ogawa M., Maruyama T., Hasegawa T., Kanaya T., Kobayashi F., Tochino Y., Uda H. 1989. The inhibitory effect of neonatal thymectomy on the incidence of insulitis in non-obese diabetes (NOD) mice. Biomed. Res. 6: 103
7. + T cell subsets are required for the transfer of diabetes in nonobese diabetic mice. J. Immunol. 140: 52-58
8. Rothe H., Hibino T., Itoh Y., Kolb H., Martin S. 1997. Systemic production of interferon-gamma inducing factor (IGIF) versus local rIFN-γ expression involved in the development of Th1 insulitis in NOD mice. J. Autoimmunity 10: 251-256
9. Rothe H., Faust A., Schade U., Kleemann R., Bosse G., Hibino T., Martin S., Kolb H. 1994. Cyclophosphamide treatment of female non-obese diabetic mice causes enhanced expression of inducible nitric oxide synthase and interferon-gamma, but not interleukin-4. Diabetologia 37: 1154-1158
10. Finter N.B. 1986. The classification and biological functions of the interferons. J. Hepatol. 3: S157-S160
11. Williams J.G., Jurkovich G.J., Maier R.V. 1993. Interferon-γ: A key immunoregulatory lymphokine. J. Surg. Res. 54: 79-93
12. Foulis A.K., McGill M., Farquharson M.A. 1991. Insulitis in Type 1 (insulin-dependent) diabetes mellitus in man-macrophages, lymphocytes, and interferon-γ containing cells. J. Pathol. 165: 97-103
13. Pukel C., Baquerizo H., Rabinovitch A. 1988. Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-γ, tumor necrosis factor, lymphotoxin and interleukin-1. Diabetes 37: 133-136
14. Markmann J.F., Jacobson J., Roza J., Fox I.J., Strome P., Naji A. 1987. Increased cytotoxic T lymphocytic killing of isolated islet cells after interferon treatment. Surg. Forum. 38: 354-356
15. Tovo P.A., Cerutti F., Palomba E., Salomone C., Pugliese A. 1984. Evidence of circulating interferon-γ in newly diagnosed diabetic children. Acta Paeditr. Scand. 73: 785-788
16. Debray-Sachs M., Carnaud C., Boitard C., Cohen H., Gresser I., Bedossa P., Bach J-F. 1991. Prevention of diabetes in NOD mice treated with antibody to murine rIFN-γ. J. Autoimmunity 4: 237-248
17. Nicoletti F., Meroni P.L., Landolfo S., Gariglio M., Guzzardi S., Barcellini W., Lunetta M., Mughini L., Zanussi C. 1990. Prevention of diabetes in BB/Wor rats treated with monoclonal antibodies to interferon-γ. Lancet 336: 319
18. Sarvetnick N., Liggitt D., Pitts S.L., Hansen S.E., Stewart T.A. 1988. Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma. Cell 52: 773-782
19. Serreze D.V., Chapman H.D., Post C.M., Johnson E.A., Suarez-Pinzon W.L. 2001. Th1 to Th2 cytokine shifts in nonobese diabetic mice: Sometimes an outcome, rather than the cause, of a diabetes resistance elicited by immunostimulation. J Immunol. 166(2): 1352-1359
20. Serreze D.V., Post C.M., Chapman H.D., Johnson E.A., Lu B., Rothman P.B. 2000. Interferon-gamma receptor signaling is dispensable in the develoment of autoimmune type 1 diabetes in NOD mice. Diabetes 49: 2007-2011
21. Garchon H.J., Luan J.J., Eloy L., Bedossa P., Bach J.F. 1994. Genetic analysis of immune dysfunction in non-obese diabetic (NOD) mice: Mapping of a susceptibility locus close to the Bcl-2 gene correlates with increased resistance of NOD T cells to apoptosis induction. Eur. J. Immunol. 24: 380-384
22. Jun H.S., Yoon C.S., Zbytnuik L., van Rooijen N., Yoon J.W. 1999. The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J. Exp. Med. 189: 347-358
23. Serreze D.V., Leiter E.H. 1988. Defective activation of T suppressor cell function in non-obese diabetic mice. Potential relation to cytokine deficiencies. J. Immunol. 140: 3801-3807
24. Herberman R.B. 1984. Interferon and cytotoxic effector cells. In Interferons and The Immune System. Vilcek, DeMaeyer, eds. Elsevier, Amsterdam, pp. 61-84
25. Roilides E., Blake C., Holmes A., Pizzo P.A., Walsh T.J. Granulocyte-macrophage colony-stimulating factor and interferon-gamma prevent dexamethasone-induced immunosuppression of antifungal monocyte activity against Aspergillus fumigatus hyphase. J. Med. Vet. Mycol. 34(1): 63-69
26. Reed S.G. 1988. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. J. Immunol. 140: 4342-4347
27. Uchida A., Yanagawa E., Kokoschka E.M., Micksche M., Koren H.S. 1984. In vitro modulation of human natural killer cell activity in interferon. Generation of adherent suppressor cells. Br. J. Cancer 50: 483-492
28. Yasunami R., Bach J.F. 1988. Anti-suppressor effect of cyclophosphamide on the development of spontaneous diabetes in NOD mice. Eur. J. Immunol. 18: 481-484
29. Yoon J.W. 1992. Studies on autoimmunity for T-cell-mediated beta-call destruction. Distinct diffeences in beta-cell destructoin between CD4+ and DC8+ T-cell clones derived from lymphocytes infiltraing the islets of NOD mice. Diabetes 41: 998-1008
30. d monoclonal antibody. Diabetes 40: 1203-1209
31. null mice are diabetes and insulitis resistant. Diabetes 505-509
32. Serreze D.V., Gaskins H.R., Leiter E.H. 1993. Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J. Immunol. 150(6): 2534-2543
33. Van de Stolpe A., van der Saag P.T. 1996. Intercellular adhesion molecule-1. J. Mol. Med. 74: 13-33
34. Weber C., Calzada-Wack J.C., Goretzki M., Pietsch A., Johnson J.P., Ziegler-Heitbrock H.W. 1995. Retinoic acid inhibts basal and interferon-gamma-induced expression of intercellular adhesion molecule 1 in monocytic cells. J. Leukoc. Biol. 57: 401-406
35. Yagi N., Yokono K., Amano K., Nagata M., Tsukamoto K., Hasegawa Y., Yoneda R., Okamoto N., Moriyama H., Miki M. 1995. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells acclerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes. Diabetes 44: 744-752
36. Martin S., Hibino T., Faust A., Kleemann R., Kolb H. 1996. Differential expression of ICAM-1 and LFA-1 versus L-selectin and VCAM-1 in autoimmune insuliits of NOD mice and association with both Th-1 and Th-2 type infiltrates. J. Autoimmunity 9: 637-43
37. Kuchroo V.K., Das M.P., Brown J.A., Ranger A.M., Zamvil S.S., Sobel R.A., Weiner H.L., Nabavi N., Glimcher L.H. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80(5): 707-718
38. Lombardi G., Arnold K., Uren J., Marelli-Berg F., Hargreaves R., Imami N., Weetman A., Lechler R. 1997. Antigen presentation by interferon gamma-treated thyroid follicular cells inhibits interleukin-2 (IL-2) and supports IL-4 production by B7-dependent human T cells. Eur. J. Immunol. 27(1): 62-71
39. Yokozeki H., Katayama I., Ohki O., Arimura M., Takayama K., Matsunaga T., Satoh T., Umeda T., Azuma M., Okumura K., Nishioka K. 1997. Interferon gamma differentially regulates CD80 (B7-1) and CD86 (B7-2/B70) expression on human langerhans cells. Br. J. Dermatol. 136: 831-837
40. Dahlen E., Hedlund G., Dawe K. 2000. Low CD86 expression in the non-obese diabetic mouse results in the impairment of both T cells activation and CTLA-4 upregulation. J. Immunol. 164: 2444
41. Colucci F., Bergman M-L., Penha-Goncalves C., Cilio C.M., Holmberg D. 1997. Apoptosis resistance of nonobese diabetic peripheral lymphocytes linked to the Idd5 diabetes susceptibility region. Proc. Natl. Acad. Sci. 94: 8670-8674
42. Zen K., Masuda J., Ogata J. 1996. Monocyte-derived macrophages prime peripheral T cells to undergo apoptosis by cell-cell contact via ICAM-1/LFA-1 dependent mechanism. Immunobiology 195: 323-333
43. Boise L.H., Noel P.J., Thompson C.B. 1996. CD28 and apoptosis. Curr. Opin. Immunol. 7: 620-625
44. Rabinovitch A. 1998. An update on cytokines in the pathogenesis of insulin-dependent diabetes mellitus. Diabetes-Metabolism Reviews 14(2): 129-151
45. Brok H.P.M., Heidt P.J., van der Meide P.H., Zurcher C., Vossen J.M. 1993. Interferon-γ prevents graft-versus-host disease after allogeneic bone marrow transplantation in mice. J. Immunol. 151: 6451-6459
46. Marth T., Zeitz Z., Ludviksson B., Strober W., Kelsall B. 1998. Murine model of oral tolerance. Induction of Fas-mediated apoptosis by blockade of interleukin-12. Ann. N.Y. Acad. Sci. 859: 290-294
47. Burchett S.K., Weaver W.M., Westall J.A., Larsen A., Kronheim S., Wilson C.B. 1988. Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes. J. Immunol. 140: 3473-3481
48. Hoffman-Goetz L., Keir R., Young C. 1986. Modulation of cellular immunity in malnutrition: Effect of interleukin 1 on suppressor T cell activity. Clin. Exp. Immunol. 65: 381-286
49. Sadelain M.W.J., Qin H.Y., Lauzon J., Singh B. 1990. Prevention of type 1 diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39: 583-589
50. Sadelain M.W.J., Qin H.Y., Sumoski W., Parfrey N., Singh B., Rabinovitch A. 1990. Prevention of diabetes in the BB rat by early immunotherapy using Freund's adjuvant. J. Autoimmunity 3: 671-680
51. Ulaeto D., Lacy P.E., Kipnis D.M., Kanagawa O., Unanue E.R. 1992. T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant. Proc. Natl. Acad. Sci. USA 89: 3927-3932
52. Shehadeh N.N., La Rosa F., Lafferty K.J. 1993. Altered cytokine activity in adjuvant inhibition of autoimmune diabetes. J. Autoimmunity 6: 291-300
53. Sobel D.O., Newsome J. 1997. Gamma interferon prevents diabetes in the BB rat. Clin. Diag. Immunol. Lab 4: 764-768
54. DeMaeyer E., DeMaeyer-Guignaud J. 1988. Production of rIFN-γ by T cells and modulation of T cell, B cell, NK cell activity by interferon. In Interferons and Other Regulatory Cytokines. John Wiley & Sons, New York, pp. 221-223
55. Wilson C.A., Jacobs C., Baker P., Baskin D.G., Dower S., Lernmark A., Toivola B., Vertrees S., Wilson D. 1990. IL-1β modulation of spontaneous autoimmune diabetes and thyroiditis in the BB rat. J. Immunol. 144: 3784-3788
56. Trembleau S., Penna G., Bosi E., Mortara A., Gately M.K., Adorini L. 1995. IL-12 administration induces Th1 cells and accelerates autoimmune diabetes in NOD mice. J. Exp. Med. 181: 817-821
57. O'Hara R.M., Henderson S.L., Nagelin A. 1996. Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice. Ann. NY Acad. Sci. 795: 241-249